Search

everythinglearnresearchcommunity

for

Search:↓

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Proper control of β-catenin activity is crucial for development and preventing diseases like cancer.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

The top research priorities for congenital ichthyosis include long-term side effects of oral retinoids, best topical treatments, and treatments for itch and hair loss.

Blood stem cells are diverse, influenced by many factors, and understanding them is key for progress in regenerative medicine.

Biologics for severe asthma have known side effects, but some new risks need more study.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Vaccination is the most effective way to reduce COVID-19 transmission.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Pharmacists play a crucial role in personalized therapy, health literacy, and patient care across various health conditions.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.